Abstract
This study analyses variables as predictors for both positive outcomes and dropout in undergoing inpatient treatment for alcohol use disorder (AUD). Retrospective in nature, it analyses patient treatment evaluations spanning a 25-year timeframe with a 5-year follow-up on positive outcomes. The sample consists of 820 inpatients who underwent AUD treatment. A set of 30 grouped variables was applied: socio-demographic data, clinical characteristics and therapy characteristics. Seventy-one percent successfully completed treatment. Six variables were defined as predictors of treatment outcome: education-level attained, employment, duration of alcohol dependence, abstinence upon admission to hospital, sponsor presence and use of disulfiram in treatment. The presence of sponsors and disulfiram in treatment are all net positives to successful treatment outcomes. Moreover, patients who have not achieved a minimum secondary school education are unemployed or at the onset of their alcohol addiction may require particular attention due to their higher risk of dropping out.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Alcoholism is an ongoing, serious global issue (Carvalho et al., 2019). The World Health Organization (WHO) estimates that 2.6% of the world’s population over the age of 15 regularly abuses alcohol (WHO, 2018), with 15–40% of the general global adult population engaging in harmful drinking (Kuntsche et al., 2017). Exacerbating the social costs is the associated ones which also drain on public resources (Laramée et al., 2013). Complicating matters in fighting against alcoholism is that treating alcohol use disorder (AUD) is extremely complex (Sliedrecht et al., 2019). Given these specific factors affecting public health as well as limitations for treatment, gaining better cognition of what predictors most affect treatment outcomes is crucial to the therapeutic process in order to ensure that those who struggle with alcoholism are better able to proceed successfully through therapy.
Given the background as a public health issue difficult to treat, this study is designed to establish factors to better predict positive outcomes as well as dropouts of intensive hospitalised treatment of AUD. Doing so is essential to illuminate the risk factors for voluntary early cessation of treatment that may otherwise have hitherto not received due attention as dropout factors. Although the literature is replete with predictors, the predictive factors examined either are separately or are too specific. Therefore, our study seeks to create a set of robust factors derived from patient samples collected during 25 years of clinical practice.
Positive and Negative Outcome Predictors in Treating AUD
Factors in predicting whether a patient shall be able to successfully undergo treatment for AUD vary. The literature offers a variety of indicative factors on those who are more likely to be successful when undergoing AUD treatment as well as determining factors for an increased risk of dropping out (Aguiar et al., 2012).
There are a number of established socio-demographic characteristics that are factors in successful AUD treatment (Hansen et al., 2020). Being in a state of matrimony is a positive factor (Murphy & Turgoose, 2019). One’s gender may lead to higher completion rates with men being more likely to be diagnosed with AUD (Boschloo et al., 2012) and women being less likely to seek treatment (García-Marchena et al., 2023). Employment is a critical factor as wishing to retain one’s job may act as an incentive for those who are already employed (Henkel, 2011). An indicated family history of exposure to alcohol abuse from family members to minors is also a factor in predicting remission and relapse (Koenig et al., 2020).
Beyond the socio- or economic factors, clinical features of treatment also play an important determinant (Hansen et al., 2020). Early contact with alcohol as well as long-term abuse is found to have a negative impact (Das et al., 2020). Moreover, the presence of any psychiatric comorbidity may also actively interfere in positive treatment outcomes (Kelly et al., 2012).
Approaches to Treatment of AUD
Theoretical approach also affects treatment outcome (Nyhuis et al., 2018), such as combining psychotherapy and psychopharmacotherapy leading to the best outcomes (Ray et al., 2020) with the administration of disulfiram found to be highly effective (Mutschler et al., 2011). Studies suggest group psychotherapy to be the “method of choice” in treating AUD (Lo Coco et al., 2019); more specifically, group and family therapy based on a systems approach has been demonstrated to be beneficial in treating addictions due to its comprehensiveness (Komashie et al. 2021; Savic et al. 2017).
The therapeutic approach specific to treatment for this study is based on the systems theory which defocuses the ethology of the disorder from the individual to the environment (predominantly in the family) that has a significant role in developing disorders (McCrady, 1989; Steinglass, 2009). The Systemic Therapy of AUD (STA) is based on systemic family therapy in treating alcoholism under controlled hospital conditions which is evaluated in our study by assessing predictors of both successful completion and dropouts.
Given these clinical and background factors, this study aims to find significant and robust factors (i.e. clinical characteristics of treatment as well as socio-demographic patient background) that may inform on the positive outcome of AUD treatment through a comprehensive evaluation of inpatient treatment for AUD, comparing dropouts to positive treatment outcomes. We have, in our study, tried to unify factors that are relatively ready to assess in order to assemble a composite of significant variables which clinicians may use at the onset of treatment in order to better determine dropout risks and directly intervene with such patients.
Material and Methods
Present Study
As a retroactive study, data was collected on patients who underwent inpatient treatment for AUD from 1987 to 2012 at the Clinic for Substance Abuse of the Institute of Mental Health (Belgrade, Serbia) to create a sample for further analysis against available assigned variables. All inpatients spanning from this timeframe were included in the sample as per the criteria for their hospitalisation. All patients who successfully completed their inpatient treatment were subjected to a follow-up of 5 years to assess their capacity to remain abstinent.
Given the expansive data sample size covering 25 years, an analysis was conducted for every fifth year within this given timeframe (i.e. 1987, 1992, 1997, 2002, 2007 and 2012) which amounts to a total of 820 patients. Our predictors were both robust and non-time sensitive as the score of predictors were based on six time points over a 25-year period. Apart from 1987, in which the 9th Revision of the International Classification of Diseases and Related Health Problems (ICD-9) was applied (WHO, 1977), the ICD 10th revision (ICD-10) (WHO, 1992) was used to diagnose alcohol dependence and other present psychopathology. Nevertheless, there are no differences in the diagnosing criteria for AUD between these two ICD classifications.
Sample
A total of 820 alcohol-dependent patients were hospitalised within these given years. The inclusion criteria are diagnosed AUD (with or without comorbidities) and over 18 years of age. The exclusion criteria were the presence of any primary psychiatric disorders conjoined with alcohol abuse and severe psychoorganic syndrome (note: these are also the indications and contraindications by the STA for inpatient treatment). The sample consists of 165 (20.1%) women and 655 (79.9%) men. While the sample age ranged from 18 to 73, its mean was 42.14 (SD = 9.83).
Variables
A positive outcome was measured as full completion of inpatient treatment (i.e. all phases of treatment) after which the medical board deemed the patient to have successfully completed the programme. These patients were then released into outpatient care who then regularly screened the patients. Those who remained consistently abstinent for 1 year following their inpatient treatment were screened at random intervals over the subsequent 4 years.
This research uses three sets of independent variables of ten variables each (30 variables in total); these variables were present in all patients’ medical records as standard procedure:
-
1.
Socio-demographic data: gender, age, birth order, level of education attained, employment, housing independence, history of legal problems, marital status, length of marriage, number of children, family composition, academic performance in secondary school and presence of alcoholism in the family.
-
2.
Clinical features: drinking habits, initial contact with alcohol, duration of AUD, decline of alcohol tolerance, alcoholic amnesia (“blackouts”), alcohol type preferred, total duration of abstinence achieved upon admission to hospital, somatic comorbidity (chronic diseases), neuropsychiatric comorbidity and presence of any additional addictions.
-
3.
Characteristics of the therapeutic process: duration of inpatient treatment, presence of withdrawal syndrome upon admission, detoxification on admission, professional consequences of alcoholism as motive for treatment, number of previous treatments undertaken, presence of sponsors in treatment and use of disulfiram.
These independent variables present the potential prognostic factors (predictors) of successful treatment outcomes defined through the dependent variable outcome of hospital treatment. According to the STA, the primary endpoint of hospital treatment is completed inpatient treatment, with any cessation of treatment considered to be a failure (i.e. dropout).
Hospital treatment consists of planned 24-h-a-day inpatient treatment. Patients attended daily group therapy with attending sponsors also participating every day permitting for occasional sponsor absences. Based on STA, intensive treatment requires approximately 8 weeks. The therapeutic model also incorporates pharmacotherapy together with a number of significant cognitive-behavioural therapy techniques. The treatment itself is divided into three phases: (Aguiar et al., 2012) psychoeducational ending with an exam in AUD (2 to 3 weeks), (Boschloo et al., 2012) self-insight into alcohol dependence and its consequences (4 weeks) and (Brorson et al., 2013) planning the future and analysis of the therapeutic process (2 weeks). Following their successful completion of the inpatient programme, patients were transferred to the outpatient programme which consisted of 1 year of one-on-one counselling with a psychiatrist under the same state care structure on a regular basis.
Statistical Analysis
Using descriptive (absolute and relative numbers (N), %, measuring central tendency and variability) as well as analytical statistical methods (difference and correlation analysis), this study employs parametric (t test) and nonparametric (Chi-square test, Chi-square, Mann-Whitney U test) tests to analyse parameters of positive outcomes and dropouts. To analyse correlation, a multivariate binary logistic regression was used whereby the dependent variable was hospitalisation outcome in conjunction with two values: (1) hospital treatment not completed and (2) hospital treatment completed. Independent variables in the model were those which had proved their significance for treatment outcome in the univariate analysis. The data were processed using the SPSS 20.0 software package (IBM Corporation). All p values lower than 0.05 were considered to be significant.
Results
Socio-demographic Predictors of Positive Treatment Outcome vs. Dropout
Of the total number of alcohol-dependent inpatients admitted to hospital (N = 820), 582 (71%) completed their STA, while 238 (29%) dropped out. Table 1 lays out the most important socio-demographic variables affecting treatment outcomes. Age was a significant factor in the outcome of treatment (t = 2.242, p < 0.05). Dropouts were generally younger (M = 40.84, SD = 10.48) against those completing inpatient treatment (M = 42.55, SD = 9.66). The largest dropout was among those up to 29 years of age (42.0%), contrasted against those 50 to 59 years of age where the dropout rate was lowest (24.3%).
From those who successfully completed STA, 28.4% experienced a relapse within 6 months; 71.6% remained abstinent for 2 years and 19.4% for 5 years following original successful completion of inpatient treatment.
As dropout rates decreased in relation to previous education achieved, education itself was found to be an important variable. Having completed one’s secondary school education was a clear factor in determining dropouts (X2 = 15.633; p <0.05). Employment was also a significant variable because dropouts were higher among the unemployed (37.6%) than the employed (25.7%). Although it may be a local determinant, the patient sample had a slightly higher representation of those employed through state-sector jobs (74.8%) than the private sector (69.8%). Based on housing dependence, the dropout rate was lower for patients domiciled in their own residence (26.5%) compared to those domiciled with their parents/family. Dropout was also higher among those reporting to be financially dependent on family as well (35.4%). Criminal history was found to be a factor predicting higher dropout (41.7%) in comparison to those without (28.0%).
A history of familial alcohol abuse was not a significant factor distinguishing the two comparable groups, bearing no determinable effect on hospitalisation outcomes from the sample (p = 0.950).
All other socio-demographic variables were found to have no statistical significance in relation to their influence on the outcome of STA.
Clinical Features of Positive Treatment Outcome vs. Dropout
Table 2 presents the significant patient variables affecting treatment outcome. Early contact with alcohol (> 7 years of age) led to a higher dropout rate (41.7%), thereby sequentially decreasing and tapering to 23.8% for those who engaged in drinking only after 30 (significant linear correlation p <0.05). Nonetheless, the following variables were not established to be of importance for the STA outcome (p = 0.173): drinking habits, decline of alcohol tolerance, alcoholic amnesia (“blackouts”), alcohol type preferred, somatic comorbidity (chronic diseases), neuropsychiatric comorbidity and presence of any additional addictions.
The greatest risk for dropping out which significantly affected positive outcomes was among patients who had reported to have a history of alcohol dependence in duration of up to 5 years (41.3%) prior to seeking treatment.
Confirmed by a significant linear correlation (p <0.005), duration of abstinence on admission to hospital was also an important variable as longer the abstinence on admission was matched by a greater likelihood of a positive outcome.
Characteristics of the Therapeutic Process Affecting Treatment Outcome
The average treatment duration for those completing STA was 55.5 days (SD = 21.68), while it was 19 days (SD = 18.67) for those who dropped out. The difference in the duration of treatment between these two groups was statistically significant (t = 17.650; p < 0.001).
Alcohol dependent patients admitted to the hospital for the first time were more likely to drop out (30.7%) compared to patients treated for a second time or more (25.2%). However, this difference was not found to be significant on final treatment outcomes (p = 0.110).
Table 3 shows that seeking treatment as a means to retain employment significantly affects treatment outcome (p = 0.001). Most dropouts were those who had been motivated to seek treatment by their family (35.1%). The importance of sponsors in treatment in relation to outcome was confirmed by the dropout rate in patients who had sponsors (27.7%) being significantly lower than in those who had none (41.9%). Among sponsor patients, those who had a workplace peer as a sponsor successfully completed treatment (91.2%). Parents as sponsors, in contrast, led to the lowest completion of treatment (65.7%). The application of aversive therapy (disulfiram) proved to be an essential factor in positive outcomes: the dropout rate for those receiving disulfiram was 20.2%, in stark contrast to those who did not (59.1%).
Robust Predictors of Treatment Outcome
Applying the binary logistic regression model to the ten significant variables obtained by the univariate statistics, six variables stood out (Table 4) thereafter defined as STA outcome predictors for hospitalised alcohol-dependent patients (Nagelkerke R Square = 0.243).
Of the socio-demographic variables, the outcome of hospital treatment was significantly affected by the characteristics of the patient’s education and employment. Among clinical features, duration of alcohol dependence and duration of abstinence upon admission to hospital most determined a positive outcome. For the therapeutic process itself, the results of treatment were significantly influenced by the presence of a sponsor and disulfiram in treatment.
Discussion
Seventy-one percent successfully completed STA, which is significant in view of the treatment’s complexity and its average total length (55 days). Of these, 71.6% continued to regularly attend outpatient treatment without entering relapse within the first 2 years following hospitalisation. In stark contrast is the 19-day average duration of treatment among dropouts (29% of the total sample), which coincides with completion of only the psychoeducational phase and not with the patient’s examination of their AUD or changing their dysfunctional patterns of behaviour. Accordingly, this timing of average dropout points to their first stabilising but abandoning any arduous, long-lasting treatment that would require deeper psychological change.
By analysing the data obtained, a model to predict outcomes of treatment was created based on six variables that significantly influence the outcomes of inpatient treatment of AUD patients (i.e. predictors of treatment outcome): (1) education, (2) employment, (3) duration of alcohol dependence, (4) duration of abstinence upon admission to hospital, (5) presence of sponsor in treatment and (6) application of disulfiram during treatment.
Education attained is an important predictor in positive treatment outcome, as there is a clear linear correlation in the likelihood to drop out and lower education. While anyone may grow to become alcohol dependent regardless of education attained, research does suggest education serves a protective role against alcoholism (Grant et al., 2012). Conversely, higher education may also reduce motivation to seek treatment due to increased awareness of social stigma (Schuler et al., 2015). Even so, education itself is a factor of distinction in the therapeutic process (Brorson et al., 2013). It would appear that the higher educated the patient is, the more likely they are to possess personality traits that will allow them to recognise their AUD and take steps to resolve it. The less educated a patient is, the less likely they are to have the same traits to resolve their AUD (Sawayama et al., 2012).
Employment was an important factor for positive patient outcomes. Fearing the loss of employment is associated with being capable of perceiving threats to oneself; in the context of treatment, this same fear allows the patient to recognise self-harm and potential threats from AUD which may also push the patient to seek and complete treatment (López-Goñi et al., 2012; Piontek et al., 2017). Our study’s results indicate that employed AUD patients are less likely to drop out than those who are unemployed. Potential loss of employment may also act as an incentive to complete treatment.
Duration of alcohol dependence is a predictor of treatment outcome (p = 0.043). Patients who completed treatment were more likely to report a dependence duration of 10 to 20 years (74.8%), in contrast to those who had a duration of > 5 years (58.7%). Shorter duration of AUD may not provide the patient with enough time to accept their dependence as well as not give a history of negative addiction impact to act as an incentive to complete treatment (Aguiar et al., 2012; Elbreder et al., 2011; Ray et al., 2017).
The duration of alcohol abstinence on admission to hospital as a predictor indicates that the longer the abstinence, the higher the chances of treatment success. The largest dropout rate was among patients who reported to have not abstained from alcohol on admission to hospital (34.8%). The negative outcomes of non-abstinent patients may be attributed to their inability to handle withdrawal and seeking admission to treatment as a way to stabilise. These patients may report the need to “take a break from drinking” but are not interested in treatment (Nguyen et al., 2020; Preuss et al., 2012). This predictor may act as a modulator of treatment outcome to be implemented at the triage stage of inpatient admission to treatment.
The significance of the predictor inclusion of sponsors in the therapeutic process to treatment outcome was confirmed by its binary logistic regression. Treatment outcome was not only significantly affected by the presence of a sponsor but was further affected by relationship type of the sponsor to the patient: lowest in parents (65.7%) and highest among work peers (91.2%). This disparity may be attributed to fear of family stigmatisation as well as tolerance of parents to their children, whereas professional relationships may show minimal tolerance (McCann & Lubman, 2018; McCrady et al., 2018). Outcomes proved to be worse when patients had no sponsor (58.1%), aligning with results in the literature (Hunter-Reel et al., 2012; O'Farrell & Clements, 2012).
As with Elbreder et al. (2010), the use of disulfiram proved to be the most significant predictor. Although regularly used, disulfiram remains controversial in treatment, with Ulrichsen et al. (2010) questioning its efficacy and benefits to its use cannot be determined in blind studies. Even so, research points to the efficacy of disulfiram in the prevention of relapse when taken under supervision of another in the patient’s environment (Skinner et al., 2014).
A possible recommendation that may be concluded from the results is that hospitalised treatment based on STA with the inclusion of disulfiram in therapy as well as the presence of cosponsors would lead to an increased positive health outcomes among those who are employed and educated as well as among those who have a reported history of alcohol dependence longer than 5 years in duration.
A further use of the results obtained herein would be more attention paid to certain patient groups or who share common factors: the unemployed, the lower educated, those who report less than 5 years of alcohol dependence and those who are unable to achieve abstinence prior to admission to the hospital. Patients high in these factors are more at risk of dropping out of treatment, possibly due to a distinct lack of motivation (i.e. not fearing loss of employment, demonstrated inability to commit as in education or have yet to feel the tangible effects of longer-term alcohol addiction) and deserve attention aimed at increasing their motivation to complete the treatment. This study, therefore, may serve as a foundation for other studies to investigate strategies to increase motivation to decrease dropout rates in AUD treatment under patients facing these factors.
Limitations
One strength of this study is that it is able to analyse for predictors of successful treatment outcome for AUD across disparate societal changes due to the overall length of the data collected. This study examined AUD. Both positive and risk factors should be approached with caution if applying to other additions.
Conclusions
A total of 71% of the sample were successful in completing their inpatient AUD treatment. Through this retrospective study, a total of 30 well-established variables were tested for their predictive potential of positive outcomes vs. dropout in AUD inpatient treatment. Only six predictors were found to be significantly indicative of positive treatment outcome: education, employment, duration of dependence, duration of abstinence upon admission, presence of sponsor and use of disulfiram in therapy.
Education, employment and duration of dependence cannot be changed, while duration of abstinence on admission to hospital, existence of sponsor in treatment and application of disulfiram are one which clinicians may influence and are therefore predictors, as well as modulators of positive treatment outcome.
Not achieving a higher education (less than secondary school or lower), unemployment and being at the onset of their alcohol dependence are all predictors that clinicians should pay particular attention to as these patients are all at a higher risk of dropping out.
Data Availability
Supporting the open science, our data may be found at https://osf.io/5jghb/?view_only=4652638f28ca4f138cd6e909e8d2a29f.
References
Aguiar, P., Neto, D., Lambaz, R., Chick, J., & Ferrinho, P. (2012). Prognostic factors during outpatient treatment for alcohol dependence: Cohort study with 6 months of treatment follow-up. Alcohol and Alcoholism, 47(6), 702–710. https://doi.org/10.1093/alcalc/ags097
Boschloo, L., Vogelzangs, N., van den Brink, W., Smit, J. H., Beekman, A. T., & Penninx, B. W. (2012). Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction, 107(9), 1639–1640. https://doi.org/10.1111/j.1360-0443.2012.03860.x
Brorson, H. H., Ajo Arnevik, E., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out from addiction treatment: A systematic review of risk factors. Clinical Psychology Review, 33(8), 1010–1024. https://doi.org/10.1016/j.cpr.2013.07.007
Carvalho, A. F., Heilig, M., Perez, A., Probst, C., & Rehm, J. (2019). Alcohol use disorders. Lancet, 394(10200), 781–792. https://doi.org/10.1016/S0140-6736(19)31775-1
Das, A., Kar, S. K., Gupta, P. K., & Dalal, P. K. (2020). A cross-sectional study of psychiatric comorbidity and severity of addiction in patients with early- and late-onset alcohol dependence. Indian Journal of Psychological Medicine, 42(4), 334–340. https://doi.org/10.1177/0253717620928443
Elbreder, M. F., de Humerez, D. C., & Laranjeira, R. (2010). The use of disulfiram for alcohol-dependent patients and duration of outpatient treatment. European Archives of Psychiatry and Clinical Neuroscience, 260(3), 191–195. https://doi.org/10.1007/s00406-009-0038-9
Elbreder, M. F., de Souza e Silva, R., Pillon, S. C., & Laranjeira, R. (2011). Alcohol dependence: Analysis of factors associated with retention of patients in outpatient treatment. Alcohol and Alcoholism, 46(1), 74–76. https://doi.org/10.1093/alcalc/agq078
García-Marchena, N., Sanvisens, A., Abellí-Deulofeu, E., et al. (2023). Sex differences in the comorbidity of patients seeking a first treatment for alcohol use disorder. International Journal of Mental Health and Addiction. https://doi.org/10.1007/s11469-023-01112-z
Grant, J. D., Scherrer, J. F., Lynskey, M. T., Agrawal, A., Duncan, A. E., Haber, J. R., Heath, A. C., & Bucholz, K. K. (2012). Associations of alcohol, nicotine, cannabis, and drug use/dependence with educational attainment: Evidence from cotwin-control analyses. Alcoholism, Clinical and Experimental Research, 36(8), 1412–1420. https://doi.org/10.1111/j.1530-0277.2012.01752.x
Hansen, E. M., Mejldal, A., & Nielsen, A. S. (2020). Predictors of readmission following outpatient treatment for alcohol use disorder. Alcohol and Alcoholism, 55(3), 291–298. https://doi.org/10.1093/alcalc/agaa018
Henkel, D. (2011). Unemployment and substance use: A review of the literature (1990-2010). Current Drug Abuse Reviews, 4(1), 4–27. https://doi.org/10.2174/1874473711104010004
Hunter-Reel, D., Witkiewitz, K., & Zweben, A. (2012). Does session attendance by a supportive significant other predict outcomes in individual treatment for alcohol use disorders? Alcoholism, Clinical and Experimental Research, 36(7), 1237–1243. https://doi.org/10.1111/j.1530-0277.2011.01719.x
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37(1), 11–24. https://doi.org/10.1016/j.addbeh.2011.09.010
Koenig, L. B., Haber, J. R., & Jacob, T. (2020). Transitions in alcohol use over time: A survival analysis. BMC psychology, 8(1), 115. https://doi.org/10.1186/s40359-020-00479-1
Komashie, A., Ward, J., Bashford, T., Dickerson, T., Kaya, G. K., Liu, Y., Kuhn, I., Günay, A., Köhler, K., Boddy, N., O’Kelly, E., Masters, J., Dean, J., Meads, C., & Clarkson, P. J. (2021). Systems approach to health service design, delivery and improvement: A systematic review and meta-analysis. BMJ Open, 11(1), e037667. https://doi.org/10.1136/bmjopen-2020-037667
Kuntsche, E., Kuntsche, S., Thrul, J., & Gmel, G. (2017). Binge drinking: Health impact, prevalence, correlates and interventions. Psychology & Health, 32(8), 976–1017. https://doi.org/10.1080/08870446.2017.1325889
Laramée, P., Kusel, J., Leonard, S., Aubin, H. J., François, C., & Daeppen, J. B. (2013). The economic burden of alcohol dependence in Europe. Alcohol and Alcoholism, 48(3), 259–269. https://doi.org/10.1093/alcalc/agt004
Lo Coco, G., Melchiori, F., Oieni, V., Infurna, M. R., Strauss, B., Schwartze, D., Rosendahl, J., & Gullo, S. (2019). Group treatment for substance use disorder in adults: A systematic review and meta-analysis of randomized-controlled trials. Journal of Substance Abuse Treatment, 99, 104–116. https://doi.org/10.1016/j.jsat.2019.01.016
López-Goñi, J. J., Fernández-Montalvo, J., & Arteaga, A. (2012). Addiction treatment dropout: Exploring patients’ characteristics. The American Journal on Addictions, 21(1), 78–85. https://doi.org/10.1111/j.1521-0391.2011.00188.x
McCann, T. V., & Lubman, D. I. (2018). Help-seeking barriers and facilitators for affected family members of a relative with alcohol and other drug misuse: A qualitative study. Journal of Substance Abuse Treatment, 93, 7–14. https://doi.org/10.1016/j.jsat.2018.07.005
McCrady, B., Wilson, A., Fink, B., Borders, A., Muñoz, R., & Fokas, K. (2018). A consumer’s eye view of family-involved alcohol treatment. Alcoholism Treatment Quarterly, 37(1), 43–59. https://doi.org/10.1080/07347324.2018.1482245
McCrady, B. S. (1989). Outcomes of family-involved alcoholism treatment. Recent Developments in Alcoholism, 7, 165–182. https://doi.org/10.1007/978-1-4899-1678-5_9
Murphy, D., & Turgoose, D. (2019). Exploring patterns of alcohol misuse in treatment-seeking UK veterans: A cross-sectional study. Addictive Behaviors, 92, 14–19. https://doi.org/10.1016/j.addbeh.2018.11.044
Mutschler, J., Dirican, G., Gutzeit, A., & Grosshans, M. (2011). Safety and efficacy of long-term disulfiram aftercare. Clinical Neuropharmacology, 34(5), 195–198. https://doi.org/10.1097/WNF.0b013e3182285e2d
Nguyen, L. C., Durazzo, T. C., Dwyer, C. L., Rauch, A. A., Humphreys, K., Williams, L. M., & Padula, C. B. (2020). Predicting relapse after alcohol use disorder treatment in a high-risk cohort: The roles of anhedonia and smoking. Journal of Psychiatric Research, 126, 1–7. https://doi.org/10.1016/j.jpsychires.2020.04.003
Nyhuis, P. W., Niederhofer, E., Scherbaum, N., Schifano, F., Bonnet, U., Dembski, N., Niederhofer, A., Specka, M., & Tenbergen, M. (2018). Effectiveness of psychoanalytic-interactional group therapy vs. behavioral group therapy in routine outpatient treatment of alcohol-dependent patients. Substance Use & Misuse, 53(3), 426–431. https://doi.org/10.1080/10826084.2017.1334065
O'Farrell, T. J., & Clements, K. (2012). Review of outcome research on marital and family therapy in treatment for alcoholism. Journal of Marital and Family Therapy, 38(1), 122–144. https://doi.org/10.1111/j.1752-0606.2011.00242.x
Piontek, D., Kurktschiev, S., Kraus, L., Hölscher, S., Rist, F., Heinz, T., Scherbaum, N., Bender, S., & Buchholz, A. (2017). “This treatment can really help me”- A longitudinal analysis of treatment readiness and its predictors in patients undergoing alcohol and drug rehabilitation treatment. Alcoholism, Clinical and Experimental Research, 41(6), 1174–1181. https://doi.org/10.1111/acer.13383
Preuss, U. W., Zimmermann, J., Schultz, G., Watzke, A., Schmidt, P., Löhnert, B., & Soyka, M. (2012). Risk profiles of treatment noncompletion for inpatients and outpatients undergoing alcohol disorder rehabilitation treatment. Substance Abuse and Rehabilitation, 3, 35–42. https://doi.org/10.2147/SAR.S24980
Ray, L. A., Bujarski, S., Yardley, M. M., Roche, D., & Hartwell, E. E. (2017). Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: Do they matter? The American Journal of Drug and Alcohol Abuse, 43(6), 703–710. https://doi.org/10.1080/00952990.2017.1312423
Ray, L. A., Meredith, L. R., Kiluk, B. D., Walthers, J., Carroll, K. M., & Magill, M. (2020). Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: A systematic review and meta-analysis. JAMA Network Open, 3(6), e208279. https://doi.org/10.1001/jamanetworkopen.2020.8279
Savic, M., Best, D., Manning, V., & Lubman, D. I. (2017). Strategies to facilitate integrated care for people with alcohol and other drug problems: A systematic review. Substance Abuse Treatment, Prevention, and Policy, 12(1). https://doi.org/10.1186/s13011-017-0104-7
Sawayama, T., Yoneda, J., Tanaka, K., Shirakawa, N., Sawayama, E., Ikeda, T., Higuchi, S., & Miyaoka, H. (2012). The predictive validity of the Drinking-Related Cognitions Scale in alcohol-dependent patients under abstinence-oriented treatment. Substance Abuse Treatment, Prevention, and Policy, 7, 17. https://doi.org/10.1186/1747-597X-7-17
Schuler, M. S., Puttaiah, S., Mojtabai, R., & Crum, R. M. (2015). Perceived barriers to treatment for alcohol problems: A latent class analysis. Psychiatric Services, 66(11), 1221–1228. https://doi.org/10.1176/appi.ps.201400160
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H. J. (2014). Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis. PLoS One, 9(2), e87366. https://doi.org/10.1371/journal.pone.0087366
Sliedrecht, W., de Waart, R., Witkiewitz, K., & Roozen, H. G. (2019). Alcohol use disorder relapse factors: A systematic review. Psychiatry Research, 278, 97–115. https://doi.org/10.1016/j.psychres.2019.05.038
Steinglass, P. (2009). Systemic-motivational therapy for substance abuse disorders: An integrative model. Journal of Family Therapy, 31, 155–174. https://doi.org/10.1111/j.1467-6427.2009.00460.x
Ulrichsen, J., Nielsen, M. K., & Ulrichsen, M. (2010). Disulfiram in severe alcoholism--An open controlled study. Nordic Journal of Psychiatry, 64(6), 356–362. https://doi.org/10.3109/08039481003686180
World Health Organization. (1977). International statistical classification of diseases and related health problems (9th ed.). WHO.
World Health Organization. (1992). International statistical classification of diseases and related health problems (10th ed.). WHO.
WHO. (2018). Global status report on alcohol and health 2018. Geneva: World health Organization. https://iris.who.int/bitstream/handle/10665/274603/9789241565639-eng.pdf
Acknowledgements
The authors wish to acknowledge the input of Timothy Johnston in the composition and editing of the text for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
Owing to its nature as a retrospective study, the study strictly adheres to the recommendations on the privacy of participants and was also approved by the Ethics Committee of the Institute of Mental Health and the Ethics Committee of the Faculty of Medicine (Belgrade University, Serbia).
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mladenovic, I., Perunicic-Mladenovic, I. & Dimitrijević, I. Clinical and Background Risk Factors Affecting Dropouts from Alcohol Use Disorder Treatment: a 25-Year Retrospective Study. Int J Ment Health Addiction (2023). https://doi.org/10.1007/s11469-023-01196-7
Accepted:
Published:
DOI: https://doi.org/10.1007/s11469-023-01196-7